Skip to main content
. 2020 Jun 4;11:2817. doi: 10.1038/s41467-020-16309-2

Fig. 3. p53 loss bypasses requirement for AGO2 during PDAC progression.

Fig. 3

a Kaplan–Meier tumor-free survival of AGO2+/+;KRASG12D;Trp53fl/+;p48Cre, AGO2fl/+;KRASG12D;Trp53fl/+;p48Cre, and AGO2fl/fl;KRASG12D;Trp53fl/+;p48Cre mice. b Chart showing PDAC (within the pancreas), the different metastatic lesions, and abnormal pathologies (black boxes) observed in each mouse of the indicated genotypes. c Representative H&E and AGO2 IHC in the indicated genotype. Scale bar, 100 µm.